相关实验视频
Updated: Sep 16, 2025

06:44
A Mouse Model for Chronic Pancreatitis via Bile Duct TNBS Infusion
Published on: February 28, 2021
4.1K
热热素抑制慢性胰腺炎和胰腺癌,通过阻断介素33的表达,抑制胰腺癌
An-Na Bae1, Mahsa Mortaja2,3, YeePui Yeung2,3
1Department of Anatomy, School of Medicine, Keimyung University, Daegu 42601, Republic of Korea.
Cancers
|July 12, 2025
概括
作为一种抗恶心药物,托皮塞特龙有效地抑制了Interleukin 33 (IL-33) 的表达. 这一发现为预防慢性炎症和相关癌症,包括胰腺癌提供了一种新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 慢性炎症是癌症发展的重要驱动因素.
- 介素33 (IL-33) 在易患癌症的慢性炎症中起着关键作用.
- 在启动炎症和癌症方面,IL-33作为细胞因子和核蛋白的双重功能需要进一步研究针对性疗法.
研究的目的:
- 为了研究热热对IL-33表达的影响.
- 评估热中药在抑制胰腺炎和相关胰腺癌方面的潜力.
- 为了确定可以抑制IL-33的促炎和促癌功能的小分子.
主要方法:
- 对食品和药物管理局 (FDA) 批准的1018种药物的查,以确定IL-33抑制剂.
- 通过检查IRF3激活来评估热热对IL-33表达的影响.
- 在胰腺炎和胰腺炎介导的胰腺癌的小鼠模型中评估西的疗效.
主要成果:
- 热热被确定为一种强大的IL-33表达抑制剂.
- 热热有效地通过抑制IRF3激活来阻止IL-33的表达.
- 在临床前模型中,Tropisetron显示显著抑制胰腺炎及其进展为胰腺癌.
结论:
- 托皮塞特朗作为一种干白素33 (IL-33) 抑制剂.
- 热热呈现了一种有前途的新型治疗策略,用于治疗慢性胰腺炎.
- 这种药物为预防和治疗与慢性炎症相关的癌症提供了潜在的新方法.
相关概念视频
Chronic Pancreatitis I: Introduction
166
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
166
Chronic Pancreatitis II: Collaborative Care
130
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
130
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
327
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
327
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
265
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
265
Acute Pancreatitis I: Introduction
494
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
494
Drugs for Treatment of Diarrhea-Predominant IBS
303
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
303

